| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $98.6M | +27.7% |
| SG&A Expense | $24.4M | +8.6% |
| Operating Income | -$153.5M | -53.9% |
| Pre-tax Income | -$151.6M | -52.3% |
| Income Tax | $261K | -9.7% |
| Net Income | -$151.8M | -52.1% |
| EPS (Basic) | -$3.93 | -49.4% |
| EPS (Diluted) | -$3.93 | -49.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.7M | -85.3% |
| Current Assets | $177.6M | -35.7% |
| Total Assets | $208.2M | -35.6% |
| Current Liabilities | $64.1M | +244.3% |
| Total Liabilities | $67.4M | +60.8% |
| Stockholders' Equity | $140.9M | -50.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$101.5M | -24.3% |
| Capital Expenditures | $15.1M | +36.3% |
| Investing Cash Flow | -$88.5M | -212.8% |
| Financing Cash Flow | $125K | -99.9% |
| Free Cash Flow | -$116.6M | -25.8% |